Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BICYCLE trial of bosentan for exercise-induced pulmonary arterial hypertension in adults with congenital heart disease
NL-OMON20429Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in pulmonary arterial hypertension (PAH) comparing Bosentan with Placebo (2 arms). Primary endpoint: Change in mean pulmonary arterial pressure at peak exercise. Planned start Jan 2013; status: not yet recruiting.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NL-OMON20429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20429.